Diversified Healthcare (DHC) came out with quarterly funds from operations (FFO) of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to FFO of $0.03 per share a year ago.
Diversified Healthcare Trust's revenue improved in Q2, but there was a growing net loss primarily due to increased interest expenses. Occupancy levels in senior housing are rising, but challenges in the medical office and life science portfolio remain. DHC faces a debt maturity wall in 2025 and 2026, with plans to refinance through secured debt deals to lower interest expenses.
Diversified Healthcare Trust (NASDAQ:DHC ) Q2 2024 Results Conference Call August 2, 2024 1:00 PM ET Company Participants Kevin Brady - Director of Investor Relations Chris Bilotto - President and Chief Executive Officer Matt Brown - Chief Financial Officer Conference Call Participants Bryan Maher - B. Riley FBR Justin Haasbeek - RBC Capital Markets Operator Good afternoon, and welcome to the Diversified Healthcare Trust Second Quarter 2024 Earnings Conference Call.
Diversified Healthcare (DHC) came out with quarterly funds from operations (FFO) of $0.03 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.05 per share a year ago.
Diversified Healthcare (DHC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Diversified Healthcare (DHC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.